Please ensure Javascript is enabled for purposes of website accessibility

If You Invested $10,000 In Aurora Cannabis' IPO, This Is How Much Money You'd Have Now

By Keith Speights – Jun 21, 2020 at 7:02AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Prepare to be underwhelmed.

Aurora Cannabis (ACB 1.64%) remains one of the most talked-about cannabis companies on the market. Its rise and fall (and the beginning of another rise) have without question intrigued investors seeking to profit from the expansion of the global cannabis industry.

The marijuana stock has made investors a lot of money over the last three months: Aurora's shares are up more than 75%. But what kind of returns have the company's early investors made? If you have invested $10,000 at Aurora's initial public offering (IPO), you might be disappointed at how much money you'd have now.

Shadow of a dollar sign on top of a pile of cannabis leaves

Image source: Getty Images.

When to begin?

We have a problem right out of the gate in determining when to begin with Aurora. It's easy if we only look at the company's debut on the New York Stock Exchange on Oct. 23, 2018. However, Aurora was a publicly-traded stock well before it listed on the NYSE.

The company listed its shares on the Toronto Stock Exchange (TSX) on July 24, 2017. We could use that as our start date in determining how much money you'd have with an initial investment of $10,000. But you could have bought shares of Aurora prior to that point, too.

Aurora moved up to the TSX from the TSX Venture Exchange. It had traded on the smaller exchange since Oct. 5, 2016. So we can use that as our beginning point, right? Um, not so fast.

Prior to listing on the TSX Venture Exchange, Aurora's shares traded on the Canadian Stock Exchange (CSE). Its predecessor company, Prescient Mining listed on the CSE in 2014.

$10,000 turned into...

If you had $10,000 in July 2014, you would have been able to buy 934 shares of the company that would soon become Aurora Cannabis. Fast forward to today, and that investment would now be worth close to $12,500. A 25% return over a five-year period isn't too exciting.

What if you had instead waited until Aurora listed on the NYSE? That $10,000 initial investment would have bought 110 shares at the market open for Aurora's NYSE debut. You'd now have at little under $1,500. That dismal 25% return over five years is starting to sound a lot better.

Since we're talking about hypothetical scenarios, let's look at how you would have fared had you bought Aurora in 2014 and sold the stock at its peak. On Jan. 23, 2018, Aurora closed at its all-time high of $141.67 per share. You would have had to be more prescient than Nostradamus to sell on that exact date. But if you had, you would have walked away with more than $132,300. 

In January 2018, Canada was still on the way to legalizing recreational marijuana. The hype about how big the market might grow had reached a fevered pitch. Aurora didn't hit its peak market cap of $11.2 billion, though, until a couple of days before the Canadian recreational pot market opened on Oct. 17, 2018. And it's been mainly downhill since then for Aurora. 

Looking ahead

Aurora's previous track record is all water under the bridge now. What really matters is what the stock does moving forward. And the jury is still out on how Aurora will fare in the future.

The company faces plenty of challenges, with its continued lack of profitability at the top of the list. Aurora's better-than-expected fiscal 2020 Q3 results bolstered hopes that the cannabis producer will be able to achieve its goal of positive adjusted EBITDA by the end of the current fiscal year. However, that still won't translate to clear-cut profitability.

On the other hand, the opportunities for Aurora are enormous. The Canadian cannabis derivatives market is just getting cranked up. Aurora is finally entering the U.S. hemp CBD market with its acquisition of Reliva. The prospects that U.S. marijuana laws could be changed in a way that allows the company to move into the huge U.S. cannabis market are looking better than they have in a while.

There's no guarantee buying Aurora Cannabis stock now won't lead to as great of a disappointment as investors who bought shares when the company first listed on the NYSE experienced. However, there's also at least a real chance that Aurora could deliver better returns than it has since it began trading on the CSE in 2014. Either way, it seems likely that Aurora Cannabis will continue to attract plenty of attention from investors looking to cash in on the expanding cannabis market.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.24 (1.64%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
326%
 
S&P 500 Returns
102%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.